AzTrials
AzTrials

PregnancyPhase 4NFP2NCT00928538

Nurse Family Partnership (NFP) Contraceptive Study

A Phase 4 study testing Enhanced NFP Care in people with Pregnancy and Effective Contraceptive Use, run by Oregon Health and Science University at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether nurses can help at-risk women reduce the incidence of unintended pregnancy by providing them access to hormonal contraceptives in their homes. Read more about this study

Who is it for?
Ages 15 to 45 years, women only
What is being tested?
Enhanced NFP Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
344 participants
Where
3 sitesUnited States
Study dates
Sep 2009to May 2015
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 45 years
  • Women only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • English or Spanish speaking (or both)
  • Enrolled in the NFP (Nurse Family Partnership) program
  • 32 weeks or less gestation.

Who cannot join

  • Not enrolled in the NFP program
  • More than 32 weeks gestation

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • Thurston County Public Health

    Olympia, Washington, 98506

  • Seattle - King County Public Health

    Seattle, Washington

  • Clark County Public Health

    Vancouver, Washington, 98666

Other trials in United States

About this study

Official title: Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy

The purpose of this study is to determine whether nurses can help at-risk women reduce the incidence of unintended pregnancy by providing them access to hormonal contraceptives in their homes.

Read the detailed description

The investigators intend to accomplish this goal by strengthening the family planning component of a well-known, effective, home-based intervention, the Nurse Family Partnership (NFP), by enhancing the nurses' access to contraceptive supplies. The investigators believe that proposed modification to the intervention, giving the nurses the ability to deliver hormonal contraception in the home, will enable the nurses to bring about greater change in the reproductive health behavior of women at-risk for unintended pregnancy. Ultimately, the investigators believe this will increase the impact the NFP has had on conception rates during the first two postpartum years.

Participants will be enrolled through the Nurse Family Partnership program in the Public Health Departments in Seattle/King County, Thurston County and Clark County, Washington. The NFP program provides home visits for women anticipating a first birth. Inclusion criteria for participation include English or Spanish speaking (or both), enrolled in the NFP program, pregnant and anticipating a first birth, and 32 weeks or less gestation. NFP nurses will obtain written consent for the study as well as consent for family planning services.

The study will be a randomized clinical trial. After consent and enrollment in the study, we will randomize participants to receive either the usual NFP intervention or the enhanced NFP intervention that includes contraceptive administration and distribution. The usual NFP intervention includes interventions focused on pregnancy planning and contraceptive advice, with the prescription and dispensing of contraceptives provided through the women's primary care settings. The primary difference between routine NFP care and the enhanced intervention is the administration and distribution of hormonal contraception in the home with one exception. Because it is part of the usual intervention, when requested, NFP nurses will provide emergency contraceptives for participants in both arms of the study. Each participant assigned to the enhanced intervention will receive the routine NFP family planning counseling beginning during pregnancy, including information on available contraceptives. The nurse will also counsel participants on when to begin using contraceptives post-partum. Following delivery, the nurse will take a history to determine whether there are any contraindications to oral contraceptives, the contraceptive patch, the contraceptive vaginal ring or the depomedroxyprogesterone shot. The nurse will follow study protocols, approved by the Clark County, Thurston County and Seattle/King County Public Health Departments, when taking the history, and if necessary, obtain a urine pregnancy test. The nurse will obtain written consent for family planning services before providing contraceptives. The written consent form is similar to consent forms used in clinic settings. The nurse will continue to provide family planning counseling, including counseling on sexually transmitted infection (STI) prevention and cervical cancer screening, and a supply of condoms. The nurse will also offer a choice of a three-month supply of combination oral contraceptives, progestin-only oral contraceptives, contraceptive patches, the contraceptive vaginal ring or a depomedroxyprogesterone injection at no cost to the participant. Depending on the contraceptive method chosen, the nurse will provide education, counseling, and obtain written request and consent forms for the specific method. All written materials will be available in English and Spanish. Monolingual Spanish-speaking patients will receive services from Spanish speaking NFP nurses. The nurses will follow guidelines and standing orders developed by Dr. Gipson, the Co-Investigator for the study, subject to approval by the county Health Officer, when providing oral contraceptives, contraceptive patches, or the contraceptive vaginal ring or when administering the depomedroxyprogesterone shot. For women currently breastfeeding, the nurse will recommend and provide progestin-only oral contraceptives or administer the depomedroxyprogesterone shot. During frequent home visits, the NFP nurse will continue to counsel the participants while providing additional three to twelve-month supplies of contraceptives or administering the depomedroxyprogesterone injections for up to two years after delivery. By phone or through subsequent visits, the nurse will address any adverse reactions or other participant concerns and will provide refills or an alternative hormonal method as necessary.

For both groups (usual NFP care and enhanced intervention), the Research Associates (RAs) will gather data related to gaps in contraceptive coverage and repeat pregnancy every three months beginning six months after delivery (except at 12 months and two years postpartum). In addition, RAs will conduct phone surveys following enrollment and again at 3 months, 12 months and 24 months post delivery. The surveys will address factors that influence the rate and timing of subsequent pregnancy, including pregnancy intendedness, utilization of reproductive health services, perceived barriers to contraceptive use, satisfaction with birth control methods, and self-efficacy related to contraceptive use.

Aim 1 is to determine whether fewer participants in the enhanced intervention group experience more than a one month gap in effective contraceptive use (defined as methods with which < 10% of women experience an accidental pregnancy during a year of typical use) compared to participants in the usual care group. The investigators will answer this by comparing the incidence of gaps that occur in the twenty-four months after delivery using survival analysis methods. Aim 2 is to examine whether fewer participants in the enhanced intervention group experience a second pregnancy compared to participants in the usual care group. The methodology for Aim 2 will be the same as for Aim 1, with analysis based on incidence of second pregnancy rather than gap in effective contraceptive use. Aim 3 will be to explore how pregnancy intendedness modifies the outcomes in Aim 1 and Aim 2, using the same methodology as aims 1 and 2.

Being tested
Enhanced NFP Care
Keywords
Female Contraception, Home Visits, CONTRACEPTIVE AGENTS, CONTRACEPTIVE DEVICES

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Enhanced NFP CareOther

    Usual NFP care plus the enhanced care that includes contraceptive administration and distribution during nurse home visits. Participants will have a choice of combined hormonal contraception (oral, patches or vaginal rings)or progestin-only contraception (oral or depomedroxyprogesterone acetate injections.

Study groups in NCT00928538
Study groupRoleWhat they receive
Usual NFP CareNo interventionUsual NFP care includes pregnancy planning and contraceptive advice during nurse home visits, with the prescription and dispensing of contraceptives provided through the women's primary care settings.
Enhanced NFP CareExperimentalEnhanced NFP intervention includes usual NFP care plus the intervention that includes contraceptive administration and distribution in the home
Receives: Other: Enhanced NFP Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. One month gaps in effective contraceptive use (defined as methods with which < 10% of women experience an accidental pregnancy during a year of typical use)

    Measured: Every three months after delivery for two years

Secondary outcomes (1)
  1. Unintended pregnancy

    Measured: Every three months after delivery for two years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2009 (estimated)
  2. Study startSep 2009
  3. Primary completionMay 2013
  4. Study completionMay 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
344 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00928538
Sponsor's protocol ID
832
Acronym
NFP2
Status last verified
Mar 2016
First submitted
25 Jun 2009
Last updated
30 Mar 2016
Results posted
No
Data monitoring committee
No

Publications

  • Melnick AL, Rdesinski RE, Creach ED, Choi D, Harvey SM. The influence of nurse home visits, including provision of 3 months of contraceptives and contraceptive counseling, on perceived barriers to contraceptive use and contraceptive use self-efficacy. Womens Health Issues. 2008 Nov-Dec;18(6):471-81. doi: 10.1016/j.whi.2008.07.011. Epub 2008 Oct 15.

    PubMed 18926726
  • Rdesinski RE, Melnick AL, Creach ED, Cozzens J, Carney PA. The costs of recruitment and retention of women from community-based programs into a randomized controlled contraceptive study. J Health Care Poor Underserved. 2008 May;19(2):639-51. doi: 10.1353/hpu.0.0016.

    PubMed 18469433

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Enhanced NFP Care in people with Pregnancy and Effective Contraceptive Use, run by Oregon Health and Science University at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

One month gaps in effective contraceptive use (defined as methods with which < 10% of women experience an accidental pregnancy during a year of typical use) (time frame: Every three months after delivery for two years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00928538, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in